Met Life Investment Management, LLC Taro Pharmaceutical Industries LTD Transaction History
Met Life Investment Management, LLC
- $14.7 Billion
- Q1 2024
A detailed history of Met Life Investment Management, LLC transactions in Taro Pharmaceutical Industries LTD stock. As of the latest transaction made, Met Life Investment Management, LLC holds 4,336 shares of TARO stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,336Holding current value
$0% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding TARO
# of Institutions
93Shares Held
4.64MCall Options Held
7KPut Options Held
6.3K-
Krensavage Asset Management, LLC New York, NY648KShares$012.16% of portfolio
-
Black Rock Inc. New York, NY616KShares$00.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny571KShares$00.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX520KShares$00.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA284KShares$00.16% of portfolio
About TARO PHARMACEUTICAL INDUSTRIES LTD
- Ticker TARO
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 37,584,600
- Description
- Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...